海王英特龍2023年第一季度報告

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

2023 Third Q%5Cuarterly Report 第三季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s

2019 First Q%5Cuarterly Report 第一季度報告 1深圳市海王英特龍生物技術(shù)股份有限公司 2019年第一季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHA

（於中華人民共和國註冊成立之股份有限公司） 股份代號 （於中華人民共和國註冊成立之股份有限公司） 2014 First Q%5Cuarterly Report 2014 第一季度業(yè)績報告 * 僅供識別之用 * For identification p%5Curpose only 香港聯(lián)合交易所有限公司（「聯(lián)交所

海王英特龍秉持「健康成就未來」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺，發(fā)展細胞因子類蛋白質(zhì)治療藥物和預(yù)防用生物制品，創(chuàng)建以自主知識產(chǎn)權(quán)產(chǎn)品研發(fā)和專業(yè)化營銷能力為代表的核心競爭力，逐步確立國內(nèi)市

海王英特龍秉持「健康成就未來」的理念，以現(xiàn)代生物技術(shù)與藥物制劑技術(shù)為創(chuàng)新平臺，發(fā)展細胞因子類蛋白質(zhì)治

Third Q%5Cuarterly Report 2022第三季度報告 CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as

CHARACTERISTICS OF GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED (THE “STOCK EXCHANGE”) GEM has been positioned as a market designed to accommodate s